Dianthus Therapeutics (DNTH) Accumulated Depreciation & Amortization: 2017-2025
Historic Accumulated Depreciation & Amortization for Dianthus Therapeutics (DNTH) over the last 2 years, with Sep 2025 value amounting to $277,000.
- Dianthus Therapeutics' Accumulated Depreciation & Amortization rose 65.87% to $277,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $940,000, marking a year-over-year increase of 79.05%. This contributed to the annual value of $193,000 for FY2024, which is 98.97% up from last year.
- Latest data reveals that Dianthus Therapeutics reported Accumulated Depreciation & Amortization of $277,000 as of Q3 2025, which was up 10.80% from $250,000 recorded in Q2 2025.
- Over the past 5 years, Dianthus Therapeutics' Accumulated Depreciation & Amortization peaked at $277,000 during Q3 2025, and registered a low of $30,000 during Q4 2022.
- Its 3-year average for Accumulated Depreciation & Amortization is $171,333, with a median of $167,000 in 2024.
- Data for Dianthus Therapeutics' Accumulated Depreciation & Amortization shows a peak YoY surged of 223.33% (in 2023) over the last 5 years.
- Dianthus Therapeutics' Accumulated Depreciation & Amortization (Quarterly) stood at $30,000 in 2022, then surged by 223.33% to $97,000 in 2023, then spiked by 98.97% to $193,000 in 2024, then spiked by 65.87% to $277,000 in 2025.
- Its Accumulated Depreciation & Amortization was $277,000 in Q3 2025, compared to $250,000 in Q2 2025 and $220,000 in Q1 2025.